|
|
Dextroamphetamine (Latest Articles)
Latest indexed articles for 'Dextroamphetamine'
Articles 171 to 180 of 200:
Paradoxical constitutive behavioral sensitization to amphetamine in mice lacking 5-HT2A receptors.
17 May 2007
RATIONALE: Although locomotor response to d-amphetamine is considered as mediated by an increased release of dopamine in the ventral striatum, blockade of either alpha1b-adrenergic or 5-HT2A receptors almost completely inhibits d-amphetamine-induced ...
rec_pub_17510759-paradoxical-constitutive-behavioral-sensitization-amphetamine-mice.htm
Riluzole and D-amphetamine interactions in humans.
16 May 2007
In preclinical studies, medications which decrease glutamate release have been shown to block some of the effects of psychostimulants. One such medication is riluzole, marketed for the treatment of Amyotrophic Lateral Sclerosis (ALS). The goal of ...
rec_pub_17714844-riluzole-d-amphetamine-interactions-humans.htm
Similar discriminative-stimulus effects of D-amphetamine in women and men.
11 May 2007
The results of controlled non-human animal and human laboratory studies are mixed regarding whether women and men respond differently to stimulant drugs. In order to assess potential gender differences in the effects of D-amphetamine, we conducted a ...
rec_pub_17561238-similar-discriminative-stimulus-effects-d-amphetamine-women-men.htm
3 May 2007
Accumulating evidence suggests that estradiol might be responsible for the enhanced response to psychostimulants sometimes observed in females. In this study, 10 healthy pre-menopausal women who were using oral, hormone-based birth control learned ...
rec_pub_17544491-evaluation-estradiol-administration-discriminative-stimulus-subject.htm
Schedules of controlled substances: placement of lisdexamfetamine into schedule II. Final rule.
May 2007
With the issuance of this final rule, the Deputy Administrator of the Drug Enforcement Administration (DEA) places the substance lisdexamfetamine, including its salts, isomers and salts of isomers into schedule II of the Controlled Substances Act ...
rec_pub_17520775-schedules-controlled-substances-placement-lisdexamfetamine-schedule.htm
May 2007
This paper outlines methodological challenges encountered in producing an independent economic evaluation for the National Institute for Health and Clinical Excellence (NICE) to inform its technology appraisal process. The analysis used to highlight ...
rec_pub_17476538-methodological-issues-undertaking-independent-cost-effectiveness.htm
29 Apr 2007
rec_pub_17539056-lisdexamfetamine-dimesylate.htm
29 Apr 2007
Acute and repeated psychostimulant administration induces a long-lasting enhanced behavioural response to a subsequent drug challenge, known as behavioural sensitization. This phenomenon involves persistent neurophysiological adaptations, which may ...
rec_pub_17537495-changes-proenkephalin-mrna-expression-forebrain-areas-amphetamine.htm
Update on drugs for hyperactivity in childhood.
29 Apr 2007
In 2001, we concluded that methylphenidate or dexamfetamine can be useful adjunctive therapy for children with severe hyperactivity in whom non-drug approaches alone have been inadequate. Since then, atomoxetine (pronounced a-toe-moks-e-teen; ...
rec_pub_17536494-update-drugs-hyperactivity-childhood.htm
29 Apr 2007
The CB(1) cannabinoid receptor antagonist SR-141716A (Rimonabant) markedly diminishes the behavioral effects of opiates and nicotine and has been an important tool to ascertain the role of cannabinoid receptors in drug addiction. The present goal ...
rec_pub_17532007-analogs-sr-141716a-rimonabant-alter-d-amphetamine-evoked-3h-dopamine.htm
Results: [1-10] [11-20] [21-30] [31-40] [41-50] [51-60] [61-70] [71-80] [81-90] [91-100] [101-110] [111-120] [121-130] [131-140] [141-150] [151-160] [161-170] [171-180] [181-190] [191-200]